Treatment of patients with metastatic renal cell carcinoma who have failed low dose intensity interleukin-2 with high-dose intravenous recombinant interleukin-2
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interleukin-2 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 19 Dec 2013 Biomarkers information updated
- 23 Aug 2005 New trial record.